Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
---|
05/31/2007 | WO2006134144A3 Process of producing bleach boosters |
05/31/2007 | CA2630860A1 Urea derivatives useful as calcium receptor modulators |
05/30/2007 | EP1603923B1 Metal complexes |
05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
05/30/2007 | CN1972913A Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
05/29/2007 | US7223765 3-[4-(3,4-Dichlorophenyl)piperazin-1-yl]-1-(2,3-dihydro-1H-indol-1-yl)propan-1-one or salts for example; psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder; high affinity for dopamine D4 receptors |
05/24/2007 | WO2007058583A2 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
05/24/2007 | US20070117797 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
05/24/2007 | CA2629831A1 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
05/23/2007 | EP1786778A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
05/23/2007 | EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
05/23/2007 | CN1968930A Bicyclic, nitrogen-containing heterocycles aromatase inhibitors |
05/23/2007 | CN1968929A Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
05/22/2007 | US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease |
05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
05/22/2007 | US7220759 Isoquinoline compound and pharmaceutical use thereof |
05/22/2007 | CA2219692C S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
05/18/2007 | WO2007002313A3 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants |
05/16/2007 | EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
05/16/2007 | EP1784390A2 Substituted benzofused heterocycles |
05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
05/16/2007 | CN1964976A Extraction of alkaloids from opium |
05/16/2007 | CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof |
05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
05/15/2007 | US7217740 Diarylsulfones as 5-HT2A antagonists |
05/15/2007 | US7217728 For therapy of reperfusion injury |
05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
05/10/2007 | WO2007025709A3 Organic compounds |
05/10/2007 | WO2006120525A3 Processes for the preparation of nelfinavir and new crystalline form of nelfinavir mesylate |
05/10/2007 | US20070105838 Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases |
05/10/2007 | US20070105834 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide |
05/10/2007 | DE60119336T2 Verwendungen von thaliporphin oder seinen derivaten in der behandlung von herzkrankheiten und seine herstellung Uses of thaliporphine or its derivatives in the treatment of heart diseases and its production |
05/09/2007 | CN1960991A Tetrahydro-imidazo [1,5-A] pyridin derivatives as aldosterone synthase inhibitors |
05/09/2007 | CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) |
05/09/2007 | CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands |
05/09/2007 | CN1958568A A kind of compound for preventing or curing infection of helicobacter pylori, preparation method, and application |
05/08/2007 | US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases |
05/08/2007 | US7214689 Isoquinoline compounds |
05/08/2007 | CA2276098C Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines |
05/03/2007 | WO2007050124A1 Fused piperidine derivatives and their uses as therapeutic agents |
05/03/2007 | WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
05/03/2007 | CA2623879A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
05/02/2007 | EP1778642A1 5-ht7 receptor antagonosts |
05/02/2007 | EP1778641A1 5-ht7 receptor antagonists |
05/02/2007 | EP1778640A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
05/02/2007 | EP1778639A2 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
05/02/2007 | EP1778206A2 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof |
05/02/2007 | EP1458707B1 New Indol-2-one derivatives |
05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
05/02/2007 | CN1956962A Tetrahydroisoquinoline sulfonamide derivatives, the preparation method thereof, and the use of the same in therapeutics |
05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
05/01/2007 | US7211585 N-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-propyl]-2-methyl-5-nitro-benzenesulfonamidehydrochloride; selective ligands of the 5-HT7 receptor; treating Central nervous system disorders |
05/01/2007 | US7211584 N-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-propyl]-2-methyl-5-nitro-benzenesulfonamidehydrochloride; selective ligands of the 5-HT7 receptor; treating Central nervous system, pain, sleep disorder, shift worker syndrome, jet lag, depression, seasonal affective disorder, migraine, anxiety, psychosis |
04/26/2007 | WO2007047991A1 Tetrahydroisoquinoline as lxr modulators |
04/26/2007 | WO2007046075A1 Piperazine derivatives as antimalarial agents |
04/26/2007 | US20070093522 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide |
04/26/2007 | CA2623213A1 Piperazine derivatives as antimalarial agents |
04/25/2007 | EP1776119A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
04/25/2007 | EP1572661B1 Crystalline form of quinapril hydrochloride and process for preparing the same |
04/25/2007 | CN1312132C 1-benzyl tetrahydro isoquinoline compound, its preparing process and use thereof |
04/24/2007 | US7208601 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants |
04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
04/18/2007 | EP1774968A1 Benzylisoquinoline derivative- or bisbenzylisoquinoline derivative-containing psychotropic agent, analgesic and/or antiphlogistic, and health food |
04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
04/18/2007 | EP1773817A1 Substituted aryl-amine derivatives and methods of use |
04/18/2007 | EP1773774A2 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
04/18/2007 | EP1773773A1 Amido compounds and their use as pharmaceuticals |
04/18/2007 | EP1773763A1 Lysine based compounds |
04/18/2007 | CN1950085A 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
04/18/2007 | CN1310890C Isoquinoline derivatives |
04/17/2007 | US7205315 Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
04/17/2007 | US7205314 Compounds for the treatment of dementia related diseases |
04/17/2007 | US7205313 Central nervous system disorders; analgesics; headaches |
04/12/2007 | US20070082907 Peroxisome proliferator activated receptor modulators |
04/11/2007 | EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
04/11/2007 | CN1946696A Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity |
04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
04/10/2007 | USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease |
04/10/2007 | US7202381 Compounds as opioid receptor modulators |
04/10/2007 | US7202364 ortho-substituted with a fused (hetero)arylamino group, e.g., carboxymethyl 2-(6-chloro-5-indanylamino)phenylacetate; treatment of COX-2 dependent disorders including rheumatoid arthritis, osteoarthritis, dysmenorrhea, pain, tumors or inflammation |
04/10/2007 | US7202257 Ureas 1-substituted with a 5 member nitrogen-containing ring in turn substituted with an oxymethylphenyl group and 3-(hetero)aryl-substituted, e.g., 1-{3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-3-(naphthalen-1-yl)urea; used to modulate of the activation state of p38 kinase protein |
04/10/2007 | US7202253 Cycloalkyl inhibitors of potassium channel function |
04/10/2007 | CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation |
04/05/2007 | US20070078139 Phosphodiesterase 4 inhibitors |
04/05/2007 | DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen |
04/04/2007 | EP1770085A1 Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient |
04/04/2007 | EP1768654A2 Selective inhibitors of human corticosteroid syntheses |
04/04/2007 | CN1942436A Lysine based compounds |
04/04/2007 | CN1942432A Phenylethanolamine derivatives as beta-2 agonists |
04/04/2007 | CN1942428A CETP inhibitors |
04/04/2007 | CN1942186A Pyrrolidine compounds |
04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
04/03/2007 | US7199244 Cyclic amine derivatives and methods of use |
04/03/2007 | US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
03/29/2007 | WO2007033773A1 Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them |
03/29/2007 | US20070072901 1-Amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 |
03/29/2007 | US20070072884 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |